| mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
2e-05 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-05 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-05 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
5e-05 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
7e-05 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-05 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |